Related Experiment Video

Updated: Dec 31, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.9K

Medication adherence and predictive factors in patients with cardiovascular disease: A cross-sectional study

Ali Hussein Alek Al-Ganmi1,2, Abdulellah Alotaibi3, Leila Gholizadeh2

  • 1College of Nursing, University of Baghdad, Baghdad, Iraq.

Nursing & Health Sciences
|January 9, 2020
PubMed

Insights

Improving cardiac medication adherence is crucial for cardiovascular disease patients. Factors like medication refill access and patient beliefs significantly impact adherence, highlighting areas for clinical nurse intervention.

Area of Science:

  • Cardiology
  • Pharmacology
  • Health Services Research

Background:

  • Adherence to cardiac medications is vital for preventing cardiovascular disease morbidity and mortality.
  • Understanding factors influencing medication adherence is essential for patient self-management.
  • Previous research highlights the complexity of adherence in cardiovascular patients.

Purpose of the Study:

  • To evaluate medication adherence and identify contributing factors in cardiovascular disease patients.
  • To compare medication adherence between patients in a cardiac ward and those in cardiac rehabilitation.
  • To determine predictors of medication adherence in cardiovascular disease patients.

Main Methods:

  • Quantitative, cross-sectional survey design.
  • Data collected from 120 cardiovascular disease patients (89 cardiac ward, 31 cardiac rehabilitation) in Australia (Oct 2016 - Dec 2017).
  • Descriptive and regression analyses used to identify adherence levels and predictive factors.

Main Results:

  • Cardiac rehabilitation patients showed significantly lower adherence (58.1%) than cardiac ward patients (64.0%).
  • Self-efficacy was significantly associated with medication adherence in both patient groups.
  • Ability to refill medications and beliefs about cardiac medications were significant independent predictors of adherence.

Conclusions:

  • Medication adherence varies between inpatient and outpatient cardiac settings.
  • Interventions targeting medication refill accessibility and patient beliefs may improve adherence.
  • Clinical nurses can play a key role in enhancing medication self-management for cardiovascular patients.

Keywords:
beliefscardiac rehabilitationcardiovascular diseasemedication adherencemedication refillnursingpredictive factorsself-efficacy

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.8K

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
713
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
281
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
813
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
545
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
255
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
200